Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDA Reviews Will Be Risk-Based Under FDA Good Manufacturing Initiative

Executive Summary

The Center for Drug Evaluation & Research will apply a risk-based approach in considering manufacturing issues in reviewing NDAs, Office of Compliance Director David Horowitz said

You may also be interested in...



GMP Oversight Will Have FDA-Wide Coordination Under Rx Quality Council

FDA's newly formed Council on Pharmaceutical Quality will oversee implementation of the agency's pharmaceutical current good manufacturing practices initiative for the 21st century

FDA Creates Four New Drug Chemistry Divisions For CMC Evaluation

FDA's restructuring of the Office of New Drug Chemistry includes the establishment of four new divisions to separate out pre- and post-marketing functions

GMP Oversight Will Have FDA-Wide Coordination Under Rx Quality Council

FDA's newly formed Council on Pharmaceutical Quality will oversee implementation of the agency's pharmaceutical current good manufacturing practices initiative for the 21st century

Related Content

Topics

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel